Welcome to the Metastatic Breast Cancer Engagement Conference (June 22-23, 2018)

Conference organizers (the Metastasis Research Society and METAvivor Research and Support Inc.) invite key stakeholders in breast cancer metastasis (MBC) research and treatment to join us for this novel engagement conference June 22-23, 2018.  The two-day conference, located in the Stabile Research Building of the H. Lee Moffitt Cancer Center in Tampa, FL will accommodate 250 stakeholders in both lecture-style seating and in roundtable discussion groups. 

The agenda below includes: sessions highlighting the current advances in translational research and clinical MBC treatment, discussions to identify top MBC patient-desired outcomes, discussion and identification of top translational and clinical MBC research priorities addressing patient-desired outcomes, including the creation of specific clinical comparative effectiveness research questions, networking events, an educational session on how to establish peer-to-peer support groups, and discussions for identifying top barriers to stakeholder engagement in MBC research.

**We are in the process of applying for CME accreditation of some conference sessions.

Conference Objectives

1. Engage and educate stakeholders (patients, clinicians, researchers) in translational metastasis research and clinical comparative effectiveness research (CER)
CER compares the benefits and harms of different treatment options or interventions that are already available to improve patient outcomes and quality of life relatively quickly.

2. Set research priorities for translational metastatic breast cancer research (a path forward for new treatments)

3. Set priorities for metastatic breast cancer clinical comparative effectiveness research (CER - a path forward for existing therapies)

4. Develop a sustainable model for patient engagement in metastasis research



View the agenda and a description of the 8 conference sessions here: PDF iconagenda_and_session_descriptions_mbc_conference.pdf

Target Audience

·      Metastatic breast cancer patients, caregivers and family members

·      Clinicians, clinician scientists, and translational researchers who focus on studying or treating metastatic breast cancer

·      Insurance payers who cover metastatic breast cancer treatments and diagnostics

Housing and Meals

Conference registration will include snack/drink breaks, lunch, and dinner on the 22nd, and snack/drink breaks and lunch on the 23rd.  The conference concludes before dinner.  Breakfast is not included as nearly all hotels within 5 miles of the conference venue offer a complimentary breakfast.  However, we will offer coffee, orange juice, and water in the mornings. 

You are responsible for reserving and paying for your travel and lodging.  Please click here to view a list of possible nearby hotel accommodations.  Patients in need may apply for a limited number of patient support stipends to help cover these expenses here


Registration and Cost

Save the June 22-23, 2018 date! Registration for this conference is not open yet, but will be in February of 2018.
We currently plan to have no charge for conference registration and meals (lunch, dinner, and snacks) to enable all to participate.  However, conferences such as this are only made possible through the support of Metastasis Research Society memberships and sponsorship.  Please consider joining the Metastasis Research Society today and continuing to facilitate progressive, patient-centered metastasis research worldwide.  In return, you will receive exclusive benefits.  We are open to membership from researchers/clinicians ($105-$165 options) and supporting membership from metastatic patients, caregivers, family members, and friends ($30-$55 options). Thank you!

Associated Surveys

Those participating in the Metastatic Breast Cancer conference will be asked to fill out a brief pre- and post-conference survey so that organizers can evaluate the achievement of our goals and report this evaluation anonymously to our funding source, a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (6102-MRS).  Registrants for the conference will also be asked to vote on top translational and clinical metastatic breast cancer research topics in a separate very brief survey. The survey will be anonymous, and results will be used to rank national research priorities for discussion at the conference in June.  Top priorities will later be published and shared publicly.

Conference Organizers

This conference was organized by members of the Metastasis Research Society and collaborating partners,  METAvivor Research and Support Inc. (project subcontractor), and the Sentinel Node Oncology Foundation (SNOF, project partner - Cancer Metastasis logo).



This conference was funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (6102-MRS). The conference venue space was kindly donated by the H. Lee Moffitt Cancer Center in partnership with the MRS.